Celltrion: all 84 studies
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab BiosimilarRecruitingNCT07425639
- Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and MetforminRecruitingNCT07093476Phase 3
- ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab BiosimilarRecruitingNCT06997055
- A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple SclerosisRecruitingNCT05906992Phase 3
- A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid ArthritisCompletedNCT05489224Phase 3Results posted
- A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With OsteoporosisCompletedNCT04757376Phase 3Results posted
- Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular EdemaCompletedNCT04739306Phase 3Results posted
- A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque PsoriasisCompletedNCT04673786Phase 3Results posted
- A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 InfectionCompletedNCT04602000Phase 2/3Results posted
- This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)CompletedNCT04593641Phase 1Results posted
- To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy SubjectsCompletedNCT04525079Phase 1Results posted
- To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous UrticariaCompletedNCT04426890Phase 3Results posted
- To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17CompletedNCT04295356Phase 1Results posted
- CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)CompletedNCT04205643Phase 3Results posted
- A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid ArthritisCompletedNCT04171414Phase 3Results posted
- To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy SubjectsCompletedNCT04018313Phase 1Results posted
- To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy SubjectsCompletedNCT03970824Phase 1Results posted
- CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)CompletedNCT03945019Phase 3Results posted
- A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid ArthritisCompletedNCT03789292Phase 3Results posted
- To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung CancerCompletedNCT03676192Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A InfectionTerminatedNCT03511066Phase 2Results posted
- To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed AvastinCompletedNCT03247673Phase 1Results posted
- A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RACompletedNCT03147248Phase 3Results posted
- A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative ColitisCompletedNCT02883452Phase 1Results posted
- An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing SpondylitisTerminatedNCT02557308Results posted
- An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RATerminatedNCT02557295Results posted
- To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)TerminatedNCT02326155Results posted
- To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular LymphomaCompletedNCT02260804Phase 3Results posted
- To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With RituxanCompletedNCT02162771Phase 3Results posted
- Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast CancerCompletedNCT02162667Phase 3Results posted
- PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid ArthritisCompletedNCT02149121Phase 3Results posted
- Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's DiseaseCompletedNCT02096861Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge ModelCompletedNCT02071914Phase 2Results posted
- Demonstrate Efficacy and Safety of Metastatic Breast CancerCompletedNCT01084876Phase 3Results posted
- Evaluate Safety, Efficacy and PharmacokineticsCompletedNCT01084863Phase 1/2Results posted
- Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High CholesterolCompletedNCT07564726Phase 3
- Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy VolunteersCompletedNCT07533539Phase 1
- A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male SubjectsCompletedNCT07367958Phase 1
- Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy SubjectsActive, not recruitingNCT07200986Phase 1
- Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy VolunteersCompletedNCT07158346Phase 1
- A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy VolunteersCompletedNCT07128654Phase 1
- To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy SubjectsCompletedNCT07054970Phase 1
- A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple MyelomaActive, not recruitingNCT06952478Phase 3
- A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male SubjectsCompletedNCT06951828Phase 1
- A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung CancerActive, not recruitingNCT06939595Phase 3
- A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT06738719Phase 3
- To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab)CompletedNCT06687928Phase 1
- A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe PsoriasisActive, not recruitingNCT06630559Phase 3
- Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With MetforminCompletedNCT06571591Phase 3
- Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male SubjectsCompletedNCT06037395Phase 1
- A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy VolunteersCompletedNCT05993806Phase 1
- A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and PsActive, not recruitingNCT05866614
- A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid ArthritisStatus unknownNCT05725434Phase 3
- Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy SubjectsStatus unknownNCT05617183Phase 1
- A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy VolunteersCompletedNCT05581693Phase 1
- A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy VolunteersCompletedNCT05568121Phase 1
- To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT05495568Phase 3
- Yuflyma® (Adalimumab), Patient Experience After SwitchingStatus unknownNCT05427942
- Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive SubjectsCompletedNCT05385770Phase 3
- A Food Effect Study of CT-L01 After Oral Administration in Healthy VolunteersCompletedNCT05364164Phase 1
- A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy VolunteersCompletedNCT05363592Phase 1
- A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy VolunteersCompletedNCT05363384Phase 1
- To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental OxygenWithdrawnNCT05224856Phase 3
- A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy SubjectsStatus unknownNCT05188378Phase 1
- To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy SubjectsCompletedNCT05017168Phase 1
- A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult VolunteersCompletedNCT05009368Phase 1
- A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult VolunteersCompletedNCT05002244Phase 1
- A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male SubjectsCompletedNCT04512872Phase 1
- A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South KoreaCompletedNCT04470830
- A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South KoreaCompletedNCT04470817
- Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy SubjectsCompletedNCT04428814Phase 1
- A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic CardiomyopathyTerminatedNCT04418297Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human ParticipantsCompletedNCT03918967Phase 1
- To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid ArthritisCompletedNCT03707535Phase 3
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyCompletedNCT03499704Phase 4
- CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy SubjectsCompletedNCT03446976Phase 1
- Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed HerceptinCompletedNCT02665637Phase 1
- Long-Term Efficacy and Safety of CT-P10 in Patients With RACompletedNCT01873443Phase 1
- An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1CompletedNCT01571219Phase 3
- An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1CompletedNCT01571206Phase 1
- Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence TrialTerminatedNCT01534949Phase 1
- Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid ArthritisCompletedNCT01534884Phase 1
- Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)CompletedNCT01220518Phase 1
- Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)CompletedNCT01217086Phase 3